Interleukin-12 Antagonist [EPC]

69768 reported adverse events

Drugs of this class: USTEKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 10009
1 OFF LABEL USE 7457
2 PSORIASIS 5232
3 PRODUCT USE ISSUE 4124
4 PRODUCT DOSE OMISSION ISSUE 3587
5 FATIGUE 3528
6 CROHN^S DISEASE 3349
7 PAIN 3261
8 ARTHRALGIA 3058
9 HEADACHE 2899
See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 469 0.6253
1 RED BLOOD CELL SEDIMENTATION RATE 123 0.5279
2 RHEUMATIC FEVER 562 0.5233
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 69 0.4964
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1513 0.4490
5 RHEUMATOID FACTOR POSITIVE 1338 0.4357
6 LUPUS VULGARIS 29 0.4028
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 99 0.4008
8 DUODENAL ULCER PERFORATION 814 0.2709
9 RETINITIS 143 0.2432
See all enriched reactions for Interleukin-12 Antagonist [EPC]